Novartis’ Q4 EPS down 91% to $0.69

Novartis AG announced on Wednesday its earnings per share (EPS) in the fourth quarter of fiscal 2022 in USD terms dropped 91% on a yearly basis to land at $0.69. Net sales amounted to $12.7 billion, d…